Ethical approval on Neuren Pharmaceuticals’ Angelman drug study.

- Advertisement -

Neuren Pharmaceuticals (NEU) has received ethics approval to proceed with the phase two clinical study of a treatment for Angelman syndrome in Australia. Angelman syndrome is defined by significant developmental delay and learning difficulties, which manifest as….Read More

Hot this week

What Does VietJet See in Sri Lanka? A New Route Offers Clues

With the recent establishment of VietJet Air's new office...

Bangladesh health system under pressure: Measles outbreak kills 500+ children!

Bangladesh (Commonwealth Union)_ Bangladesh is battling its worst measles...

Could Tomato-Soy Juice Help Reduce Inflammation in Adults with Obesity?

A new study suggests that drinking tomato-soy juice every...

Iran Halts Negotiations Temporarily, Opens Door for Future Diplomatic Solutions in Lebanon

Iran has paused its negotiations with the United States...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories